UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Anti-Alzheimer drink has no efficacy: civic group
Medical experts are increasingly raising suspicions over whether Handok’s n...
by So Jae-hyeon
|
2018-10-24 15:22
라인
Sales of antidiabetic SGLT-2 inhibitors expand in Q3
Antidiabetic drugs using sodium-glucose cotransporter 2 (SGLT-2) inhibitor ...
by So Jae-hyeon
|
2018-10-23 14:26
라인
Shingles vaccines likely to become cheaper
With local shingles vaccines rolled out, the prices of shingles vaccines ar...
by So Jae-hyeon
|
2018-10-22 17:05
라인
L&C BIO sets offering price at ₩24,000 for KOSDAQ debut
L&C BIO, a tissue engineering company, said on Friday that it has set its o...
by So Jae-hyeon
|
2018-10-22 14:12
라인
Trivalent flu shots out of stock, quadrivalent products selling poorly
Pharmaceutical companies aggressively marketed new quadrivalent flu vaccine...
by So Jae-hyeon
|
2018-10-18 13:59
라인
Developing natural product-derived drugs gets trickier under Nagoya Protocol
Korean pharmaceutical companies are struggling to develop new drugs out of ...
by So Jae-hyeon
|
2018-10-18 12:00
라인
Drug regulator raids 4 cell therapy makers
The pharmaceutical industry is paying keen attention to why the Ministry of...
by So Jae-hyeon
|
2018-10-16 15:28
라인
‘AI-based drug development to broaden gap between pharmaceuticals’
Local pharmaceutical firms should brace for a new era where drugmakers take...
by So Jae-hyeon
|
2018-10-15 15:37
라인
[News Focus] Handok sidesteps regulation to promote anti-Alzheimer drink
The medical community and pharmaceutical industry have raised suspicion tha...
by So Jae-hyeon
|
2018-10-15 14:52
라인
[News Focus] Celltrion to accelerate US entry on imminent FDA approval
Cellrion is expected to accelerate its move to enter the U.S. market with a...
by So Jae-hyeon
|
2018-10-12 15:40
라인
[News Focus] Authorities close in on drug firm owners in bribery case
The issue of illegal rebates is stirring the Korean pharmaceutical sector, ...
by So Jae-hyeon
|
2018-10-11 16:33
라인
Kukje Pharm CEO, executives booked for bribing doctors
A midsize Korean pharmaceutical company has been embroiled in an illegal re...
by So Jae-hyeon
|
2018-10-10 15:31
라인
Pharmaceuticals seek fresh start with new CEOs
Several pharmaceutical and biotech firms have appointed a new CEO or a vice...
by So Jae-hyeon
|
2018-10-05 15:44
라인
Daewoong to refile clinical trial plan on botulinum toxin in China
Daewoong Pharmaceutical has changed its strategy of entering the Chinese ma...
by So Jae-hyeon
|
2018-10-05 12:00
라인
GC LabCell seeks to expand indication of natural killer cell-based therapy
GC LabCell said Thursday it has received regulatory approval for a phase-1/...
by So Jae-hyeon
|
2018-10-04 14:51
라인
Pharma event to showcase AI-based solutions for new drug development
The Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KPBMA) a...
by So Jae-hyeon
|
2018-10-01 13:34
라인
Original hypertension drugs enjoy sales growth after valsartan recall
Original hypertension treatments by multinational pharmaceuticals achieved ...
by So Jae-hyeon
|
2018-09-28 15:55
라인
Korea, Belgium to hold first joint pharmaceutical conference
Korea and Belgium will hold their first joint pharmaceutical conference in ...
by So Jae-hyeon
|
2018-09-21 12:12
라인
Biois registers patent to develop TNF-alpha inhibitor
Biois Corp. said it has registered a patent on aptamers binding to tumor ne...
by So Jae-hyeon
|
2018-09-20 16:45
라인
Botulinum toxin makers to wage war in US, China in 2019
Korean makers of botulinum toxin are likely to compete against one another ...
by So Jae-hyeon
|
2018-09-18 11:51
-
1
2
3
4
5
6
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top